These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of chronic delta hepatitis with recombinant alpha 2 interferon in 8 patients with anti-human immunodeficiency virus antibodies]. Taillan B; Fuzibet JG; Pesce A; Vinti H; Gratecos N; Cassuto JP; Dujardin P Presse Med; 1988 Nov; 17(41):2200. PubMed ID: 2974582 [No Abstract] [Full Text] [Related]
4. Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses. Porres JC; Carreño V; Bartolomé J; Moreno A; Galiana F; Quiroga JA J Hepatol; 1989 Nov; 9(3):338-44. PubMed ID: 2691569 [TBL] [Abstract][Full Text] [Related]
5. Natural killer cell function during interferon treatment of delta hepatitis. Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385 [No Abstract] [Full Text] [Related]
6. Treatment of chronic delta hepatitis with recombinant human alpha interferon. Hoofnagle J; Mullen K; Peters M; Avigan M; Park Y; Waggoner J; Gerin J; Hoyer B; Smedile A Prog Clin Biol Res; 1987; 234():291-8. PubMed ID: 3628383 [No Abstract] [Full Text] [Related]
7. Alpha interferon therapy of chronic delta hepatitis: a pilot study. Di Bisceglie AM; Negro F; Smedile A; Bergmann K; Hoofnagle JH Prog Clin Biol Res; 1991; 364():393-7. PubMed ID: 2020714 [No Abstract] [Full Text] [Related]
8. Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophilia. Lee CA; Kernoff PB; Karayiannis P; Thomas HC Br J Haematol; 1989 Jun; 72(2):235-8. PubMed ID: 2503026 [TBL] [Abstract][Full Text] [Related]
9. Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis. Buti M; Esteban R; Español MT; Malagelada A; Jardi R; Rodriguez-Frias F; Roget M; Guardia J J Infect Dis; 1991 Jun; 163(6):1351-3. PubMed ID: 1674749 [TBL] [Abstract][Full Text] [Related]
10. Alpha interferon therapy in children with chronic active hepatitis B and delta virus infection. Kay MH; Wyllie R; Deimler C; Caulfield M; Steffen R; Baetz-Greenwalt B J Pediatr; 1993 Dec; 123(6):1001-4. PubMed ID: 8229507 [TBL] [Abstract][Full Text] [Related]
11. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis. Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384 [No Abstract] [Full Text] [Related]
12. [Chronic hepatitis delta--the course and approaches to therapy]. Blokhina NP; Ketiladze ES; Kelli EI; Viazov SO Klin Med (Mosk); 1991 Mar; 69(3):85-8. PubMed ID: 2067348 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis. Tocci G; Antonelli L; Boumis E; Colaiacomo M; Guarascio P; Struglia C; Tossini G; Visco G Arch Virol Suppl; 1992; 4():306-7. PubMed ID: 1450710 [TBL] [Abstract][Full Text] [Related]
14. Management of hepatitis D virus infection. Rizzetto M J Gastroenterol Hepatol; 1991; 6 Suppl 1():23-5. PubMed ID: 1751800 [No Abstract] [Full Text] [Related]
15. [The clinico-morphological characteristics and efficacy of interferon therapy in patients with chronic delta hepatitis]. Kokoreva LN; Zmyzgova AV; Shalygina NB; Maksimov SL Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):55-9. PubMed ID: 8184615 [TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with delta hepatitis using interferon. Actis GC; Maran E; Rizzetto M Arch Intern Med; 1986 Oct; 146(10):2081. PubMed ID: 3767558 [No Abstract] [Full Text] [Related]